A phase II trial of gemcitabine in combination with oxaliplatin and capecitabine in previously untreated metasetatic or recurrent pancreatic cancer.
Sun Jin Sym
No relevant relationships to disclose
Junsik Hong
No relevant relationships to disclose
Minkyu Jung
No relevant relationships to disclose
Yang Seo Koo
No relevant relationships to disclose
Yeon Ho Park
No relevant relationships to disclose
Koen Kook Kim
No relevant relationships to disclose
Jinny Park
No relevant relationships to disclose
Eun Kyung Cho
No relevant relationships to disclose
Jae Hoon Lee
No relevant relationships to disclose
Dong Bok Shin
No relevant relationships to disclose